Semler Scientific Inc (SMLR) - Total Liabilities
Based on the latest financial reports, Semler Scientific Inc (SMLR) has total liabilities worth $136.93 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore SMLR year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Semler Scientific Inc - Total Liabilities Trend (2011–2024)
This chart illustrates how Semler Scientific Inc's total liabilities have evolved over time, based on quarterly financial data. See how much free cash does Semler Scientific Inc generate to measure how efficiently the company converts operating cash flow to free cash.
Semler Scientific Inc Competitors by Total Liabilities
The table below lists competitors of Semler Scientific Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Spear REIT Ltd
JSE:SEA
|
South Africa | ZAC2.19 Billion |
|
FibraHotel
MX:FIHO12
|
Mexico | MX$5.00 Billion |
|
Rapac Communication & Infrastructure Ltd
TA:RPAC
|
Israel | ILA1.07 Billion |
|
Alandsbanken Abp A
HE:ALBAV
|
Finland | €4.84 Billion |
|
ON24 Inc
NYSE:ONTF
|
USA | $88.91 Million |
|
Guangdong Jinming Machinery Co Ltd
SHE:300281
|
China | CN¥221.06 Million |
|
EDREAMS ODIGEO UNS.ADR/10
F:K0I
|
Germany | €860.06 Million |
|
Jiangsu Jinling Sports Equipment Co Ltd
SHE:300651
|
China | CN¥244.55 Million |
Liability Composition Analysis (2011–2024)
This chart breaks down Semler Scientific Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Semler Scientific Inc market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.97 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.30 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.23 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Semler Scientific Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Semler Scientific Inc (2011–2024)
The table below shows the annual total liabilities of Semler Scientific Inc from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $9.08 Million | +44.78% |
| 2023-12-31 | $6.27 Million | -10.65% |
| 2022-12-31 | $7.02 Million | +36.92% |
| 2021-12-31 | $5.12 Million | +5.76% |
| 2020-12-31 | $4.85 Million | -7.06% |
| 2019-12-31 | $5.21 Million | +48.00% |
| 2018-12-31 | $3.52 Million | -48.35% |
| 2017-12-31 | $6.82 Million | +13.85% |
| 2016-12-31 | $5.99 Million | +44.33% |
| 2015-12-31 | $4.15 Million | +2.14% |
| 2014-12-31 | $4.06 Million | +101.29% |
| 2013-12-31 | $2.02 Million | -60.03% |
| 2012-12-31 | $5.05 Million | +341.91% |
| 2011-12-31 | $1.14 Million | -- |
About Semler Scientific Inc
Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. The company's products serve cardi… Read more